REMI-AI Rapid Detection Module (REMI-AI RDM) is an AI-enabled medical device from Epitel, Inc, listed by FDA (510(k), K240408) with a decision date of 2024-10-17. Review panel: Neurology.
| FDA submission number | K240408 |
|---|---|
| Pathway | 510(k) |
| Company | Epitel, Inc |
| Review panel (specialty) | Neurology |
| FDA decision date | 2024-10-17 |
| Decision | Substantially Equivalent |
| Product code | OMB |
| Classification | Automatic Event Detection Software For Full-Montage Electroencephalograph |
| Device class | 2 |
| Regulation number | 882.1400 |
| Review time (calendar days) | 251 |
| Applicant country | US |
Official FDA database record · FDA AI-enabled device list
All Neurology AI devices · Full device index
Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.